Target intelligence / Profile preview

Lysosome-associated membrane glycoprotein 3 (LAMP3)

Target
LAMP3
Molecular classification
Lysosomal membrane protein, Glycoprotein, Type I transmembrane protein, Other (LAMP family member)
01

Overview

Lysosome-associated membrane glycoprotein 3 (LAMP3) is a heavily glycosylated type I transmembrane protein mainly localized on lysosomal and lysosome-related organelle membranes. Primarily expressed in mature dendritic cells in humans, LAMP3 is associated with the regulation of antigen processing and presentation in the immune response, particularly within the MHC class II compartment[1]. In the lung, LAMP3 is also highly expressed in alveolar type II cells where it localizes to lamellar bodies, important for pulmonary surfactant metabolism and homeostasis[2]. The protein has been linked to the maturation of dendritic cells, resistance to certain viral infections, modulation of apoptosis (under specific conditions, e.g., salivary gland or tumor cells), and the proliferation and survival of pathogens like Salmonella within host cells[3][4]. LAMP3 is considered a marker for dendritic cell maturation and is involved in autoimmune and respiratory diseases as well as various cancers, where it may promote metastasis or drug resistance. Although there are no therapeutics directly targeting LAMP3 as of the current knowledge, its disease associations and cell biology roles make it a candidate of interest for future drug development[1][3][4].

Other names
DC-LAMPDCLAMPTSC403CD208LAMP-3DC LAMPDC-lysosome-associated membrane glycoproteinProtein TSC403
02

Biological functions

Regulation of lysosomal integrity and functionMaturation of dendritic cellsAntigen processing and presentation (via MHC class II compartments)Surfactant homeostasis in alveolar type II cellsRegulation of apoptosis (in certain contexts)Immune response (especially dendritic cell biology)
03

Disease associations

Cancer (including metastasis association)Infection (notably pathogen interaction, e.g., Salmonella)InflammationAutoimmune disorders (e.g., role in salivary gland pathology/Sjögren's syndrome)Asthma (pulmonary surfactant regulation)
04

Safety considerations

Potential involvement in apoptotic signaling when overexpressedInvolvement in surfactant imbalance in the lung (could impact respiratory system)Immune modulation (effects on dendritic cell function and inflammation)
05

Biomarkers

Marker of dendritic cell maturationMarker for transformed type II pneumocytes (lung cancer/athology)Marker for alveolar cell differentiation

Beyond the preview

Go deeper on Lysosome-associated membrane glycoprotein 3 (LAMP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosome-associated membrane glycoprotein 3 (LAMP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call